Cargando…

Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide

BACKGROUND: Heterogeneity in B-type natriuretic peptide (BNP) levels, especially among individuals with acute heart failure with normal left ventricular ejection fraction (HFNEF), can cause confusion in interpreting results. We investigated the characteristics of cases of acute HFNEF with only modes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimamoto, Ken, Koike, Natsuha, Mizuochi, Kiyoko, Honma, Miho, Kasai, Yufuko, Sakai, Akiko, Fujita, Etsuko, Kawana, Masatoshi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636755/ https://www.ncbi.nlm.nih.gov/pubmed/19166616 http://dx.doi.org/10.1186/1471-2261-9-2

Ejemplares similares

Beta-Adrenergic Blockade Therapy for Autonomic Dysfunction is Less Effective for Elderly Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Shimamoto, Ken, et al.
Publicado: (2015)

Prevalence and characteristics of myocardial crypts in Japanese patients referred for cardiovascular magnetic resonance
por: Watanabe, Eri, et al.
Publicado: (2015)

Gender Differences in Predictors of Left Ventricular Myocardial Relaxation in Non-Obese, Healthy Individuals
por: Sekiguchi, Haruki, et al.
Publicado: (2015)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Energetic Basis for Exercise-Induced Pulmonary Congestion in Heart Failure With Preserved Ejection Fraction
por: Burrage, Matthew K., et al.
Publicado: (2021)

Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence
por: Koratala, Abhilash, et al.
Publicado: (2017)

The Relationship between Nocturnal Hypoxemia and Left Ventricular Ejection Fraction in Congestive Heart Failure Patients
por: Mirzaaghazadeh, Mohammad, et al.
Publicado: (2014)

Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction
por: Jearath, Vaneet, et al.
Publicado: (2016)

Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction
por: Tate, Samuel, et al.
Publicado: (2014)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction
por: Nonin, Shinichi, et al.
Publicado: (2018)

Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women
por: Sekiguchi, Haruki, et al.
Publicado: (2017)

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma
por: Carrizales-Sepúlveda, Edgar Francisco, et al.
Publicado: (2017)

Laparoscopic Cholecystectomy in a Cardiac Transplant Candidate with an Ejection Fraction of Less than 15%
por: Jones, Perry E., et al.
Publicado: (1998)

Sonographic chest B-lines anticipate elevated B-type natriuretic peptide level, irrespective of ejection fraction
por: Bitar, Zouheir, et al.
Publicado: (2015)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Usefulness of B‐Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion
por: Hernandez, Michelle, et al.
Publicado: (2022)

Medical Treatment in Heart Failure with Reduced Ejection Fraction: A Proposed Algorithm Based on the Patient’s Electrolytes and Congestion Status
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023)

Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Efficacy and safety of atrial fibrillation ablation in heart failure patients with left ventricular ejection fraction less than 50%
por: Sakamoto, Yusuke, et al.
Publicado: (2023)

Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide Level
por: Fujita, Shu-ichi, et al.
Publicado: (2017)

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020)

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
por: Januzzi, James L., et al.
Publicado: (2021)

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction
por: Barandiarán Aizpurua, Arantxa, et al.
Publicado: (2021)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Sex-specific temporal trends in the incidence and prevalence of hospitalized patients with preserved versus reduced left ventricular ejection fraction heart failure: A Japanese community-wide study
por: Honma, Miho, et al.
Publicado: (2015)

Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure
por: Hebl, Virginia, et al.
Publicado: (2012)

Great Tool or Gold Standard? B-Type Natriuretic Peptide and Congestive Heart Failure
por: Montez, Jeremy, et al.
Publicado: (2011)

Anaesthetic Management of Renal Transplant Surgery in Patients of Dilated Cardiomyopathy with Ejection Fraction Less Than 40%
por: Srivastava, Divya, et al.
Publicado: (2014)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Atrial natriuretic peptide reduces the ischemia/reperfusion-induced renal injury in rats by enhancing sensory neuron activation
por: Harada, N, et al.
Publicado: (2007)

Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patients
por: Wang, Ji-Hung, et al.
Publicado: (2013)

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eq19m8ton3c2aa7hj7fvu1b0ga